Adrenal Gland Mass
Learn about Adrenal Gland Mass diagnosis, including clinical documentation and medical coding for Adrenal Incidentaloma and Adrenal Tumor. Find information on healthcare best practices related to an Adrenal Gland Mass, covering diagnosis, treatment, and patient care. This resource offers guidance for accurate medical coding and appropriate clinical documentation of Adrenal Incidentaloma and Adrenal Tumor.
Growth in the adrenal gland, can be benign or cancerous.
Often asymptomatic. May cause hormonal imbalances (high blood pressure, weight gain).
Incidental discovery on imaging (CT, MRI) for other conditions.
ICD-10 Code Families
Complete code families applicable to D49.7
When to use each related code
| Description | When to use |
|---|---|
| Growth in adrenal gland, often non-cancerous. | Use for incidental findings on imaging or if symptoms relate to hormone overproduction. Consider Adrenal Cushing Syndrome or Pheochromocytoma if applicable. |
| Overproduction of cortisol by adrenal gland. | Use when clinical findings suggest cortisol excess (weight gain, moon face, hypertension). Exclude exogenous steroid use. Cortisol levels must be assessed. |
| Tumor of adrenal gland producing excess adrenaline. | Use for episodic hypertension, headaches, palpitations, sweating. Requires biochemical confirmation with elevated metanephrines. |
Best-practice checklist
- ✓Adrenal gland mass size and location documented
- ✓Characterize mass as functional or non-functional
- ✓Imaging study results (CT, MRI, etc.)
- ✓Hormone levels (cortisol, aldosterone, etc.)
- ✓Symptoms or clinical findings related to mass
Common pitfalls to avoid
Missing documentation specifying right, left, or bilateral adrenal gland involvement can lead to coding errors and claim denials.
Incomplete documentation of malignancy status (benign, uncertain behavior, primary, or metastatic) impacts accurate coding and reimbursement.
If incidentaloma is documented, further evaluation and documentation are needed to exclude functional or malignant tumors for proper coding.
Best-practice tips
- 01Document mass size, location, and imaging characteristics for accurate ICD-10 coding (e.g., D35.0).
- 02Evaluate for hormone overproduction with biochemical testing to rule out functional tumors for CDI.
- 03Review prior imaging to establish diagnosis date and assess growth rate for appropriate HCC coding.
- 04If incidentally discovered, clearly document as such and correlate with symptoms for compliant billing.
- 05Consider biopsy or resection if indicated and document rationale for medical necessity and compliance.
Step-by-step checklist
- 1
Confirm mass location within adrenal gland via imaging (ICD-10 D35.0)
- 2
Evaluate for hormone overproduction: cortisol, aldosterone, catecholamines
- 3
Assess size: <4cm consider observation, >=4cm evaluate for malignancy
- 4
Characterize mass: benign features vs concerning for malignancy (ICD-10 C74)
Ready-to-paste narrative
Patient presents with an adrenal gland mass, also known as an adrenal incidentaloma or adrenal tumor, discovered incidentally during imaging performed for unrelated reasons. The patient's current symptoms, if any, are documented, including but not limited to abdominal pain, flank pain, back pain, hypertension, unexplained weight loss or gain, fatigue, and changes in bowel habits. Physical examination findings are noted, including palpation of the abdomen and assessment for signs of Cushing syndrome, Conn syndrome, or pheochromocytoma. Differential diagnosis includes benign adrenal adenoma, adrenocortical carcinoma, pheochromocytoma, myelolipoma, and metastasis. Initial laboratory evaluation includes a comprehensive metabolic panel, complete blood count, hormonal evaluation including cortisol, aldosterone, renin, and metanephrines. Imaging studies reviewed and considered include CT scan of the abdomen and pelvis with contrast, MRI of the adrenal glands, and potentially adrenal venous sampling. Management options discussed with the patient include watchful waiting with serial imaging and hormonal evaluation, surgical resection, or further investigation to characterize the mass. The decision for surgical intervention is based on size, imaging characteristics, hormonal activity, and patient preference. Patient education provided regarding the potential risks and benefits of each treatment option. ICD-10 coding for the adrenal gland mass will be determined based on the specific diagnosis and characterization of the mass, such as D35.0 for benign neoplasm of adrenal gland, C74.1 for malignant neoplasm of adrenal gland, or E27.1 for hyperfunctioning adrenal gland. CPT codes for procedures performed, such as adrenalectomy or biopsy, will be documented appropriately. Follow-up imaging and hormonal evaluation scheduled to monitor the adrenal mass and assess for any changes.
Common questions and answers
How can I differentiate between a benign adrenal incidentaloma and a malignant adrenal tumor in a patient with an adrenal gland mass?+
Differentiating between a benign adrenal incidentaloma and a malignant adrenal tumor requires a multi-faceted approach. Begin with a thorough patient history and physical exam, focusing on symptoms such as hypertension, weight gain, or hirsutism, which can suggest hormone-producing tumors. Biochemical evaluation is crucial, including tests for plasma metanephrines to rule out pheochromocytoma, serum aldosterone and renin activity for aldosteronoma, and a 1 mg overnight dexamethasone suppression test for Cushing's syndrome. Imaging plays a vital role; consider contrast-enhanced CT to assess size, shape, and density, and MRI for further characterization if needed. Size is a significant factor, with masses greater than 4 cm warranting closer scrutiny. Explore how specific imaging characteristics, like homogenous density and rapid washout, can suggest benignity, while irregular margins and heterogeneous enhancement raise concern for malignancy. Consider implementing a follow-up imaging protocol for smaller, stable incidentalomas to monitor for growth. Ultimately, if suspicion for malignancy is high, biopsy or surgical resection may be necessary. Learn more about the role of fine-needle aspiration biopsy in the diagnosis of adrenal masses.
What is the recommended follow-up imaging protocol for an asymptomatic patient with a small, non-functioning adrenal incidentaloma discovered on abdominal CT?+
For asymptomatic patients with a small (less than 4 cm), non-functioning adrenal incidentaloma discovered incidentally on abdominal CT, the recommended follow-up imaging protocol generally involves repeat imaging at 6-12 months to assess for growth. If the incidentaloma remains stable in size and appearance after the initial follow-up, further imaging may be performed at 2-3 year intervals. However, individual patient factors, such as age, comorbidities, and family history, should be considered when determining the optimal follow-up schedule. Hormonal evaluation should also be repeated at intervals determined by initial results and clinical suspicion. Explore how the American College of Radiology Appropriateness Criteria can provide further guidance on adrenal incidentaloma management and consider implementing a standardized follow-up protocol within your practice. Learn more about the long-term risks associated with untreated adrenal incidentalomas.
When is surgical resection indicated for an adrenal gland mass, and what are the key factors clinicians should consider?+
Surgical resection of an adrenal gland mass is typically indicated when there is a high suspicion for malignancy, such as functional tumors, or in cases of rapidly growing or large (>4cm) incidentalomas. Key factors clinicians should consider include patient age, overall health, comorbidities, and the presence of symptoms. Hormone-secreting tumors, like pheochromocytoma and aldosteronoma, often require surgical intervention to control hormone excess and prevent complications. For non-functioning incidentalomas, consider factors such as size, imaging characteristics (e.g., heterogeneous enhancement, irregular margins), and patient preference when making surgical decisions. Explore how minimally invasive laparoscopic adrenalectomy has become the preferred surgical approach for most adrenal masses and learn more about the pre-operative evaluation and post-operative management of patients undergoing adrenalectomy.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.